Polyethyleneimine-functionalized boron nitride nanospheres as efficient carriers for enhancing the immunostimulatory effect of CpG oligodeoxynucleotides

References

• KriegAMYiAKMatsonSCpG motifs in bacterial DNA trigger direct B-cell activationNature199537465225465497700380
   PubMed Web of Science ®Google Scholar
• KlinmanDMImmunotherapeutic uses of CpG oligodeoxynucleotidesNat Rev Immunol200444248257
   Web of Science ®Google Scholar
• HemmiHTakeuchiOKawaiTA toll-like receptor recognizes bacterial DNANature2000408681374074511130078
   PubMed Web of Science ®Google Scholar
• WagnerHBacterial CpG DNA activates immune cells to signal infectious dangerAdv Immunol19997332936810399010
   PubMed Web of Science ®Google Scholar
• AkiraSTakedaKKaishoTToll-like receptors: critical proteins linking innate and acquired immunityNat Immunol20012867568011477402
   PubMed Web of Science ®Google Scholar
• KlinmanDMYiAKBeaucageSLConoverJKriegAMCpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gammaProc Natl Acad Sci U S A1996937287928838610135
   PubMed Web of Science ®Google Scholar
• BauerSKirschningCJHäckerHHuman TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognitionProc Natl Acad Sci U S A200198169237924211470918
   PubMed Web of Science ®Google Scholar
• StaceyKJSweetMJHumeDAMacrophages ingest and are activated by bacterial DNAJ Immunol19961575211621228757335
   PubMedGoogle Scholar
• SunSQZhangXHToughDFSprentJType I interferon-mediated stimulation of T cells by CgG DNAJ Exp Med199818812233523429858519
   PubMed Web of Science ®Google Scholar
• KriegAMCpG motifs in bacterial DNA and their immune effectsAnnu Rev Immunol20022070976011861616
   PubMed Web of Science ®Google Scholar
• FonsecaDEKlineJNUse of CpG oligonucleotides in treatment of asthma and allergic diseaseAdv Drug Deliv Rev200961325626219167442
   PubMed Web of Science ®Google Scholar
• KlinmanDMKlaschikSSatoTTrossDCpG oligonucleotides as adjuvants for vaccines targeting infectious diseasesAdv Drug Deliv Rev200961324825519272313
   PubMed Web of Science ®Google Scholar
• KriegAMTherapeutic potential of toll-like receptor 9 activationNat Rev Drug Discov20065647148416763660
   PubMed Web of Science ®Google Scholar
• MuradYMClayTMCpG oligodeoxynucleotides as TLR9 agonists therapeutic applications in cancerBio Drugs2009236361375
   Google Scholar
• KlinmanDMCurrieDGurselIVerthelyiDUse of CpG oligodeoxynucleotides as immune adjuvantsImmunol Rev2004199120121615233736
   PubMedGoogle Scholar
• MutwiriGLittel-van Den HurkSVBabiukLAApproaches to enhancing immune responses stimulated by CpG oligodeoxynucleotidesAdv Drug Deliv Rev200961322623219162103
   PubMed Web of Science ®Google Scholar
• MutwiriGKNichaniAKBabiukSBabiukLAStrategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotidesJ Control Release200497111715147800
   PubMed Web of Science ®Google Scholar
• HanagataNStructure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery systemInt J Nanomedicine201272181219522619554
   PubMed Web of Science ®Google Scholar
• SheehanJPLanHCPhosphorothioate oligonucleotides inhibit the intrinsic tenase complexBlood1998925161716259716589
   PubMed Web of Science ®Google Scholar
• HenrySPBeattieGYehGComplement activation is responsible for acute toxicities in rhesus monkeys treated with a phosphorothioate oligodeoxynucleotideInt Immunopharmacol20022121657166612469940
   PubMed Web of Science ®Google Scholar
• ChopraNGLuykenRJCherreyKBoron-nitride nanotubesScience1995269522696696717807732
   PubMed Web of Science ®Google Scholar
• GolbergDBandoYTangCCZhiCYBoron nitride nanotubesAdv Mater2007191824132432
   Web of Science ®Google Scholar
• ChenXWuPRousseasMBoron nitride nanotubes are non-cytotoxic and can be functionalized for interaction with proteins and cellsJ Am Chem Soc2009131389089119119844
   PubMed Web of Science ®Google Scholar
• JonssonESimonsenLKarlssonMLarssonRThe hollow fiber model: a new method for in vivo-evaluation of antitumor effect, toxicity and pharmacokinetics of new anticancer drugsAnn Oncol199894444
   Web of Science ®Google Scholar
• GaoZHZhiCYBandoYGolbergDSerizawaTIsolation of individual boron nitride nanotubes via peptide wrappingJ Am Chem Soc2010132144976497720297821
   PubMed Web of Science ®Google Scholar
• CiofaniGRaffaVMenciassiACuschieriABoron nitride nanotubes: an innovative tool for nanomedicineNano Today200941810
   Web of Science ®Google Scholar
• CiofaniGDantiSNittiSMazzolaiBMattoliVGiorgiMBiocompatibility of boron nitride nanotubes: an up-date of in vivo toxicological investigationInt J Pharm20134441–2858823357257
   PubMedGoogle Scholar
• CiofaniGDantiSGenchiGGPilot in vivo toxicological investigation of boron nitride nanotubesInt J Nanomedicine20127192422275819
   PubMed Web of Science ®Google Scholar
• ZhiCYMengWJYamazakiTBN nanospheres as CpG ODN carriers for activation of toll-like receptor 9J Mater Chem2011211452195222
   Web of Science ®Google Scholar
• KerkmannMCostaLTRichterCSpontaneous formation of nucleic acid-based nanoparticles is responsible for high interferon-α induction by CpG-A in plasmacytoid dendritic cellsJ Biol Chem200528098086809315591070
   PubMed Web of Science ®Google Scholar
• PutnamDGentryCAPackDWLangerRPolymer-based gene delivery with low cytotoxicity by a unique balance of side-chain terminiProc Natl Acad Sci U S A20019831200120511158617
   PubMed Web of Science ®Google Scholar
• ZhuJTangALawLPAmphiphilic core-shell nanoparticles with poly(ethylenimine) shells as potential gene delivery carriersBioconjug Chem200516113914615656585
   PubMed Web of Science ®Google Scholar
• ManoharanYJiQYamazakiTEffect of molecular weight of polyethyleneimine on loading of CpG oligodeoxynucleotides onto flake-shell silica nanoparticles for enhanced TLR9-mediated induction of interferon-alphaInt J Nanomedicine201273625363522888224
   PubMed Web of Science ®Google Scholar
• MengWJYamazakiTNishidaYHanagataNNuclease-resistant immunostimulatory phosphodiester CpG oligodeoxynucleotides as human toll-like receptor 9 agonistsBMC Biotechnol2011118821943407
   PubMed Web of Science ®Google Scholar
• TangCCBandoYHuangYZhiCYGolbergDSynthetic routes and formation mechanisms of spherical boron nitride nanoparticlesAdv Funct Mater2008182236533661
   Web of Science ®Google Scholar
• ZhuYFIkomaTHanagataNKaskelSRattle-type Fe(3)O(4)@ SiO(2) hollow mesoporous spheres as carriers for drug deliverySmall20106347147819943250
   PubMed Web of Science ®Google Scholar
• BrunotCPonsonnetLLagneauCFargePPicartCGrosgogeatBCytotoxicity of polyethyleneimine (PEI), precursor base layer of poly-electrolyte multilayer filmsBiomaterials200728463264017049374
   PubMed Web of Science ®Google Scholar
• LatzESchoenemeyerAVisintinATLR9 signals after translocating from the ER to CpG DNA in the lysosomeNat Immunol20045219019814716310
   PubMed Web of Science ®Google Scholar
• ZhangHChenSZhiCYamazakiTHanagataNChitosan-coated boron nitride nanospheres enhance delivery of CpG oligodeoxynucleotides and induction of cytokinesInt J Nanomedicine201381783179323674892
   PubMed Web of Science ®Google Scholar
• ZhangHYamazakiTZhiCHanagataNIdentification of a boron nitride nanosphere-binding peptide for the intracellular delivery of CpG oligodeoxynucleotidesNanoscale20124206343635022941279
   PubMed Web of Science ®Google Scholar
• KrugATowarowskiABritschSToll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12Eur J Immunol200131103026303711592079
   PubMed Web of Science ®Google Scholar
• HartmannGWeeratnaRDBallasZKDelineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivoJ Immunol200016431617162410640783
   PubMed Web of Science ®Google Scholar
• HartmannGKriegAMMechanism and function of a newly identified CpG DNA moth in human primary B cellsJ Immunol2000164294495210623843
   PubMed Web of Science ®Google Scholar
• GuiducciCOttGChanJHProperties regulating the nature of the plasmacytoid dendritic cell response to toll-like receptor 9 activationJ Exp Med200620381999200816864658
   PubMed Web of Science ®Google Scholar
• HondaKYanaiHNegishiHIRF-7 is the master regulator of type-I interferon-dependent immune responsesNature2005434703477277715800576
   PubMed Web of Science ®Google Scholar
• KleinDCGLatzEEspevikTStokkeBTHigher order structure of short immunostimulatory oligonucleotides studied by atomic force microscopyUltramicroscopy2010110668969320202756
   PubMed Web of Science ®Google Scholar
• ChinnathambiSChenSGanesanSHanagataNBinding mode of CpG oligodeoxynucleotides to nanoparticles regulates bifurcated cytokine induction via toll-like receptor 9Sci Rep2012253422837814
   PubMed Web of Science ®Google Scholar